medigraphic.com
ISSN 0188-2198 (Impreso)

2016, Número S3

<< Anterior Siguiente >>

Rev Mex Cardiol 2016; 27 (S3)


Factores de morbilidad y mortalidad quirúrgica en pacientes con disfunción renal crónica sometidos a revascularización miocárdica

Acuña-Tapia H, Galván-García JE

Idioma: Español
Referencias bibliográficas: 28
Paginas: 110-120
Archivo PDF: 224.54 Kb.


RESUMEN

Introducción: En la enfermedad renal crónica, la enfermedad cardiovascular es responsable del 50% de la mortalidad. En pacientes con enfermedad cardiovascular y enfermedad renal crónica, la cirugía de revascularización miocárdica está asociada con mejores tasas de supervivencia. El objetivo del estudio fue identificar los principales factores de morbilidad y mortalidad quirúrgica en pacientes con enfermedad renal crónica sometidos a cirugía de revascularización miocárdica, en una población mexicana. Métodos: El diseño del estudio fue descriptivo y retrospectivo, se incluyó la totalidad de pacientes desde marzo de 2013 a febrero de 2014. Se obtuvo la información por consulta de expediente clínico y la información se analizó con el paquete estadístico SPSS v20. Resultados: Se analizaron 352 pacientes, de los cuales se incluyeron 43 pacientes. Se encontró una prevalencia de enfermedad renal crónica del 12.21%, con una tasa de filtración glomerular promedio de 50.43 ± 6.7 mL/min/1.73 m2. La mortalidad fue del 9.3%, la necesidad de diálisis del 9.3%, la incidencia de infarto de miocardio postquirúrgico (4.7%), las complicaciones infecciosas (13.9%), y las arritmias cardiacas (20.9%). La estancia hospitalaria promedio de 24.6 ± 10.53 días. Conclusión: Con respecto a la literatura se encontró una menor prevalencia de enfermedad renal crónica entre los sometidos a cirugía de revascularización miocárdica, con mortalidad similar, y morbilidad postquirúrgica mayor.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wright RS, Reeder GS, Herzog CA et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137 (7): 563-570.

  2. National Kidney Fundation. Definition and classification of stages of chronic kidney disease. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002; 39 (Suppl 1): S1-S266. Available in: www.kidney.org/professionals/kdoqui/guidelines_ckd/toc.htm

  3. Froissart M, Rossert J, Jacquot C. Predictive performance of the modificacion of diet in renal disease and cockcroft-gault equations for estimating renal function. J Am Soc Nephrol. 2005; 16 (3): 763-773.

  4. Brosius III FC et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Circulation. 2006; 114: 1083-1087.

  5. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005; 68 (2): 429-436.

  6. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342 (20): 1478-1483.

  7. Russo D, Corrao S, Miranda I et al. Progression of coronary artery calcification in predialysis patients. Am J Nephrol. 2007; 27 (2): 152-158.

  8. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007; 20 (2): 103-109.

  9. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008; 19 (2): 213-216.

  10. Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005; 45 (4): 592-596.

  11. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003; 14: 2373-2380.

  12. American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. Guideline for Coronary Artery Bypass Graft Surgery. Circulation. 2011; 124: 652-735.

  13. Hemmelgarn BR, Southern D. Survival after coronary revascularization among patients with kidney disease. Circulation. 2004; 110 (14): 1890-1895.

  14. Holzmann MJ, Sartipy U. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting. Am J Cardiol. 2013; 112 (9): 1342-1346.

  15. Holzmann MJ, Ahlbeack E, Jeppsson A, Sartipy U. Renal dysfunction and longterm risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting. Int J Cardiol. 2013; 168: 1137-1142.

  16. Cooper WA, O’Brien SM. Impact of renal dysfunction on outcomes of coronary artery bypass surgery, results from the society of thoracic surgeons national adult cardiac database. Circulation. 2006; 113 (8): 1063-1070.

  17. James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation. 2011; 123 (4): 409-416.

  18. Holzmann MJ, Gardell C, Jeppsson A, Sartipy U. Renal dysfunction and long term risk of heart failure after coronary artery bypass grafting. Am Heart J. 2013; 166 (1): 142-149.

  19. Olsson D, Sartipy U, Braunschweig F, Holzmann MJ. Acute kidney injury following coronary artery bypass surgery and long-term risk of heart failure. Circ Heart Fail. 2013; 6 (1): 83-90.

  20. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004; 351 (13): 1285-1295.

  21. Anderson RJ, O’Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery: VA Cooperative Study #5. Kidney Int. 1999; 55 (3): 1057-1062.

  22. Szczech LA, Reddan DN. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 2001; 60 (1): 292-299.

  23. Holzmann MJ, Ahnve S, Hammar N, Jorgensen L, Klerdal K, Pehrsson K et al. Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005; 130 (3): 746-752.

  24. Holzmann MJ, Jernberg T. Long-term cardiovascular outcomes in patients with chronic kidney disease undergoing coronary artery bypass graft surgery for acute coronary syndromes. J Am Heart Assoc. 2014; 3: e000707.

  25. Brown JR, Cochran RP. Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg. 2008; 86 (1): 4-11.

  26. Zakeri R, Freemantle N, Barnett V. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005; 112 (9 Suppl.): I-270-I-275.

  27. Levey AS, Beto JA, Coronado BE, Eknoyan G. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998; 32 (5): 853-906.

  28. Serruys PW, Morice MC, Kappetein AP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease (SYNTAX). N Engl J Med. 2009; 360 (10): 961-972.




2020     |     www.medigraphic.com